COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,668 Articles (22,913 medRxiv, 8,755 bioRxiv)

Most recent first Previous |  Page 2048: Articles 20471-20480  | Next

Association between Participation in Government Subsidy Program for Domestic Travel and Symptoms Indicative of COVID-19 Infection
Miyawaki, A., Tabuchi, T., Tomata, Y., Tsugawa, Y.
10.1101/2020.12.03.20243352 — Posted: 2020-12-04
Why simple face masks are unexpectedly efficient in reducing viral aerosol transmissions
Freitag, S., Howell, S. G., Jim, K. T. C.
10.1101/2020.12.03.20243063 — Posted: 2020-12-04
Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 Antigen Rapid Test (Abbott) compared to RT-qPCR
Winkel, B. M. F., Schram, E., Gremmels, H., Debast, S. B., Schuurman, R., Wensing, A. M. J., Bonten, M. J. M., Goedhart, E., Hofstra, L. M., Antigen Rapid Test Validation Group
10.1101/2020.12.03.20243311 — Posted: 2020-12-04
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE2
Lei, Y., Zhang, J., Schiavon, C. R., He, M., Chen, L., Shen, H., Zhang, Y., Yin, Q., Cho, Y., Andrade, L., Shadel, G. S., Hepokoski, M., Lei, T., Wang, H., Zhang, J., Yuan, J. X.- J., Malhotra, A., Manor, U., Wang, S., Yuan, Z.-Y., Shyy, J. Y.-J.
10.1101/2020.12.04.409144 — Posted: 2020-12-04
Ca2+-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide
Khelashvili, G., Plante, A., Doktorova, M., Weinstein, H.
10.1101/2020.12.03.410472 — Posted: 2020-12-04
Comparative analysis of antigen-specific anti-SARS-CoV-2 antibody isotypes in COVID-19 patients
Fujigaki, H., Inaba, M., Osawa, M., Moriyama, S., Takahashi, Y., Suzuki, T., Yamase, K., Yoshida, Y., Yagura, Y., Oyamada, T., Takemura, M., Doi, Y., Saito, K.
10.1101/2020.12.04.407510 — Posted: 2020-12-04
Circulating ACE2-expressing Exosomes Block SARS-CoV-2 Virus Infection as an Innate Antiviral Mechanism
El-Shennawy, L., Hoffmann, A. D., Dashzeveg, N. K., Mehl, P. J., Yu, Z., Tokars, V. L., Nicolaescu, V., Ostiguin, C., Jia, Y., Li, L., Furlong, K., Mao, C., Wysocki, J., Batlle, D., Hope, T. J., Shen, Y., Luo, Y., Chae, Y., Zhang, H., Swaminathan, S., Randall, G. C., Demonbreun, A. R., Ison, M. G., Fang, D., Liu, H.
10.1101/2020.12.03.407031 — Posted: 2020-12-04
Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC
Yoon, H. a., Bartash, R., Gendlina, I., Rivera, J., Nakouzi, A., Bortz, R. H., Wirchnianski, A. S., Paroder, M., Fehn, K., Serrano-Rahman, L., Babb, R., Sarwar, U. N., Haslwanter, D., Laudermilch, E., Florez, C., Dieterle, M. E., Jangra, R. K., Fels, J. M., Tong, K., Mariano, M. C., Vergnolle, O., Georgiev, G. I., Herrera, N. G., Malonis, R. J., Quiroz, J. A., Morano, N. C., Krause, G. J., Sweeney, J. M., Cowman, K., Allen, S., Annam, J., Applebaum, A., Barboto, D., Khokhar, A., Lally, B. J., Lee, A., Lee, M., Malaviya, A., Sample, R., Yang, X. A., Li, Y., Ruiz, R., Thota, R., Barnhill, J., Goldstein, D. Y., Uehlinger, J., Garforth, S. J., Almo, S. C., Lai, J. R., Gil, M. R., Fox, A. S., Chandran, K., Wang, T., Daily, J. P., Pirofski, L.-a.
10.1101/2020.12.02.20242909 — Posted: 2020-12-04
Longitudinal lab test analysis confirms pre-existing anemia as a severe risk factor for post-viral clearance hospitalization in COVID-19 patients
Lenehan, P., Ramudu, E., Venkatakrishnan, A., O'Horo, J., Badley, A. D., Morice, W. G., Soundararajan, V.
10.1101/2020.12.02.20242958 — Posted: 2020-12-04
Mapping each pre-existing conditions association to short-term and long-term COVID-19 complications
Venkatakrishnan, A., Pawlowski, C., Zemmour, D., Hughes, T., Anand, A., Berner, G., Kayal, N., Puranik, A., Conrad, I., Bade, S., Barve, R., Sinha, P., O'Horo, J., Badley, A. D., Soundararajan, V.
10.1101/2020.12.02.20242925 — Posted: 2020-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).